BCMA targeted CAR T - Fred Hutchinson Cancer Center
Talvey (talquetamab-tgvs) - J&J
Tecvayli (teclistamab-cqyv) - Genmab, J&J
Carvykti (ciltacabtagene autoleucel) - J&J
Abecma (idecabtagene vicleucel) - BMS
Elrexfio (elranatamab-bcmm) - Pfizer
Lynozyfic (linvoseltamab-gcpt) - Regeneron, Sanofi
http://www.ncbi.nlm.nih.gov/pubmed/41348052
 
Danai Dima; Doris K Hansen; Rahul Banerjee
 
Dec 5, 2025
 
Next